摘要
目的:探讨重症脑出血患者原发病及抗感染的动态药学监护内容和模式。方法:结合脑出血治疗原则及并发症处理原则,将临床表现、检验结果与用药情况结合,针对患者的病情和治疗特点,将治疗分为3个阶段,每个阶段均有重点。早期:侧重原发病治疗,目标是挽救生命;中期:中枢神经感染、抗凝与脱水利尿药物的合理使用;后期:泌尿系感染、注射用头孢哌酮/舒巴坦钠与心率加快间的关系分析。制订药物治疗方案,实施全程动态药学监护。结果:结合临床情况对脑出血患者实施动态药学分析,可预测并解决在治疗中与药物相关的问题,为临床医师分析病情变化、制订治疗方案提供有力的药学支持,提高患者药物治疗的依从性、安全性和有效性。结论:结合各项临床表现,实施动态的病情和药物疗效的关系分析是危重患者救治成功的重要保证。
OBJECTIVE： To discuss the content and mode of dynamic pharmaceutical care for a severe patient with primary ce- rebral hemorrhage and secondary infections. METHODS： Combined with the therapeutic principles of cerebral hemorrhage and pro- cessing principle of complications, based on clinical manifestation, test result and medication, according to disease condition and treatment characteristics, treatment was divided into 3 stages~ the key points of each stage was as follows： early stage： focusing on the treatment for primary disease, target was life rescue; medium stage： central nervous infection, rational use of anti-coagulan- tion, drugs for dehydration and diuresis; later stage： relationship analysis of urinary infection, Cefoperazone/sulbaetam sodium for injection and increased heart rate. The drug therapy was formulated, and dynamic pharmaceutical care was carried out. RESULTS： Combined with clinical information, dynamic pharmacy analysis for the patient with cerebral hemorrhage was helpful for predicting and resolving the problems in the pharmaceutical treatment, providing a powerful pharmaceutical support for clinicians to analyze the disease and develop the treatment plan, and improving medication compliance, safety and efficacy of patients. CONCLU- SIONS： The combination of clinical manifestations, the implementation of the dynamics of the disease and drug efficacy relation- ship analysis are important guarantee for the successful treatment of critically ill patients.
出处
《中国药房》
CAS
CSCD
2014年第14期1337-1340,共4页
China Pharmacy
关键词
脑出血
动态分析
药学监护
临床药师
Cerebral hemorrhage
Dynamics analysis
Pharmaceutical care
Clinical pharmacist
